Forendo Pharma Overview

  • Founded
  • 2013
Founded
  • Status
  • Private
  • Employees
  • 24
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $2.97M
Latest Deal Amount
  • Investors
  • 8

Forendo Pharma General Information

Description

Developer of therapeutic solutions and drugs intended to assist in the treatment of women's health indications. The company specializes in the research and development of drugs that are competent in tissue-specific hormone mechanisms for the treatment of broader gynecological conditions like endometriotic lesions and polycystic ovarian syndrome (PCOS), enabling medical institutions to improve the treatment of female urological conditions efficiently.

Contact Information

Website
www.forendo.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • Itäinen Pitkäkatu 4 B
  • 7th Floor, Pharmacity Building
  • 20520 Turku
  • Finland
+358 040 0000000

Forendo Pharma Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Forendo Pharma Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC 03-Dec-2019 $2.97M 000.00 000.00 Completed Clinical Trials - Phase 1
6. Later Stage VC 17-Jul-2019 00.000 000.00 000.00 Completed Clinical Trials - Phase 1
5. Early Stage VC 05-Sep-2018 00.000 000.00 0000 Completed Clinical Trials - Phase 1
4. Debt - General 19-Mar-2018 00.00 000.00 Completed Clinical Trials - Phase 1
3. Early Stage VC (Series A) 23-Oct-2014 000.00 000.00 000.00 Completed Startup
2. Debt - General 01-Jan-2014 $4.59M Completed Startup
1. Seed Round 01-Jan-2013 $4.59M $4.59M 00.000 Completed Startup
To view Forendo Pharma’s complete valuation and funding history, request access »

Forendo Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
B1 shares 0,000 00000.00 00000.00 00 00000.00 0.000
B1 shares 0,000 00000.00 00000.00 00 00000.00 00.000
B1 shares 0,000 00000.0 00000.0 00 00000.0 0.000
Series B 2,083 $3340.7 $3340.7 1x $3340.7 13.84%
Series B 2,435 $1587.65 $1587.65 1x $1587.65 13.84%
To view Forendo Pharma’s complete cap table history, request access »

Forendo Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of therapeutic solutions and drugs intended to assist in the treatment of women's health indications. The comp
Drug Discovery
Turku, Finland
24 As of 2021
000.00
00.00 0000-00-00
0000000000 0 000.00

0000000

ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat.
000000000000000
Beijing, China
000 As of 0000
00000
0.000 0000-00-00
00000000 00000

000000 0

t esse cillum dolore eu fugiat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt
000000000000000
Mississauga, Canada
00 As of 0000
000.00
000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Forendo Pharma Competitors (41)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Jacobio Pharmaceuticals Formerly VC-backed Beijing, China 000 00000 00000000 00000
000000 00000000000 Corporation Mississauga, Canada 00 000.00 000000000 000.00
00 000000000000000 Formerly VC-backed Cambridge, MA 00 00000 000000&0 00000
0000000 Venture Capital-Backed Hannover, Germany 00 000.00 00000 00000 000.00
000 00000000(00000 Corporation Cambridge, MA 000 000.00 00000000 000.00
You’re viewing 5 of 41 competitors. Get the full list »

Forendo Pharma Executive Team (4)

Name Title Board Seat Contact Info
Risto Lammintausta Ph.D Co-Founder, Chief Executive Officer and Board Member
Pasi Koskimies Ph.D Co-Founder and Project Director
Maarit Merla Head, Business Development
You’re viewing 3 of 4 executive team members. Get the full list »

Forendo Pharma Board Members (14)

Name Representing Role Since
Anja König Ph.D Novartis Venture Fund Board Member 000 0000
Claus Andersson Ph.D Sunstone Life Science Ventures Board Member 000 0000
Cristina Csimma Ph.D Forendo Pharma Chairman 000 0000
David Colpman Forendo Pharma Board Member 000 0000
Hakan Goker Ph.D M Ventures Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

Forendo Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Forendo Pharma Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Sunstone Life Science Ventures Venture Capital Minority 000 0000 000000 0
Vesalius Biocapital Partners Venture Capital Minority 000 0000 000000 0
Finnvera Venture Capital Minority 000 0000 000000 0
Innovestor Venture Capital Minority 000 0000 000000 0
Karolinska Development Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »